Pharmacist Follow-up, a Qualitative Study of Patient Experience

Patient Satisfaction Clinical Trial

Official title:

Pharmacist Follow-up of Patients With Coronary Heart Disease. A Qualitative Study of Patient Experience.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01131715
• Other study ID #: SHAN-002
• Status: Completed
• Start date: February 2010
• Est. completion date: July 2012

Study information

• Verified date: June 2020
• Source: Hospital Pharmacy of North Norway Trust
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A pharmacist follow-up procedure is under development. Patients with coronary heart disease (CHD) is being followed up by a pharmacist for one year with three meetings; at discharge from hospital, after three months and after one year. The evaluation is basically based on quantitative measures as achievement of therapeutic goals, number of drug related problems detected, hospitalisations etc. However, the patients' own experience with the follow-up procedure cannot be evaluated using these measures. Thus, a qualitative approach is needed. In this study, a total of four patients participating in the follow-up will be included and interviewed. A semistructured interview guide will be used. Interviews will be taped, transcribed and analyzed with the intention to explore how patients experience the follow-up from the pharmacist. A thoruough content analysis will be performed. Patients included must have met the pharmacist at least twice. The pharmacist in charge of the follow-up will recruit patients and hand out study information. Patients will reply to the principal investigator of the study and thus kept anonymous for the pharmacist in charge of the follow-up. No pressure will be put on the patients to join, but it will be emphasized that it will help evaluating the procedure.

Description:

See full publication on http://www.biomedcentral.com/1756-0500/7/197 Garcia et al. BMC Research Notes 2014, 7:197

Recruitment information / eligibility

• Status: Completed
• Enrollment: 4
• Est. completion date: July 2012
• Est. primary completion date: March 2010
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• must have met the pharmacist at least twice

• living within the area of Tromsoe city so that interviews are possible

Exclusion Criteria

• none as patients are already enrolled in another study

Related Conditions & MeSH terms

• Coronary Disease
• Heart Diseases
• Patient Preference
• Patient Satisfaction

Locations

Country	Name	City	State
Norway	University of Tromsoe	Tromso

Sponsors (2)

Lead Sponsor	Collaborator
Hospital Pharmacy of North Norway Trust	University of Tromso

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Qualitative evaluation of the impact of pharmacist follow-up via interviews with the participating patients	In the pharmacist follow-up procedure under development, patients have individual "consultations" with a pharmacist three times. Patients are recruited to this study at the second or third consultation. Interviews will be performed with patients included to explore how patients' experience this follow-up procedure. Outcome measures from patient interviews can be counted. In qualitative research, the content of the interviews are thoroughly analysed with focus on the meaning of the informant's/interviewee's sayings. Outcomes will be presented as overall themes touched by the informants.	3 months or 1 year

External Links

•   Published article
•   Regional Committees for Medical and Health Research Ethics (REK)